The "Elevate" by MAPS Podcast

This podcast series will focus on how digital is transforming scientific communications.  Episode 1 will focus on the journal publishing industry, discussing how medical journal publishing is changing and what changes we might see in the future.

In this podcast, Kirk Shepard, Chief Medical Officer & SVP, Head of Global Medical Affairs OBG at Eisai, speaks with Ghazaleh EA, pharmacist and new industry professional. The conversation explores Ghazaleh's path into Medical Affairs and covers topics including the transition from training to industry, the plusses and minuses of clinical practice versus direct industry involvement, internships, challenges of finding a first position, and how to discover your specialty within the function. 

As we all know as per the FDA – October is ‘Cybersecurity Awareness Month’ and today we are going to talk and discuss about this critically important topic. Our objectives for this podcast are as follows: 1. What is medical device cybersecurity – why should you care?2. Why does the FDA and other agencies care about medical device cybersecurity?3. What are the regulatory expectations?

Objectives:At the end of this series of podcasts, the participant will be able to:Discuss the functions and activities of key external stakeholdersIdentify potential areas for compliant collaboration by MSLs with Academic Drug Developers

This podcast sponsored by VISFO explores the past, present and future of the Medical Science Liaison role, from its origin as a primarily sales-focused transactional position, to one of increasing strategic importance to the organization in which MSLs engage in a two-way dialogue with HCPs, KOLs and others within the ecosystem of external stakeholders to drive better patient care. 

Objectives:At the end of this series of podcasts, the participant will be able to:Discuss the functions and activities of key external stakeholdersIdentify potential areas for compliant collaboration by MSLs with Patient Advocacy Groups

Historically, insight gathering in life science has been a fragmented process, when it should be viewed as a single endeavor. In this discussion sponsored by Within3, learn how to eliminate the insight gaps that occur due to disparate data sets, changing stakeholders, siloed information systems, and evolving scientific narratives throughout the product development lifecycle – and how Medical Affairs teams can achieve clarity, improve business function, and reduce risk with a holistic, technology-enabled approach.

Before the pandemic most MSL/HCP engagements and advisory boards were in-person. Then during the pandemic, we largely moved to synchronous virtual — aka, we conducted our in-person engagements on Zoom. Now as we start to look beyond the pandemic, innovative Medical Affairs teams are exploring alternatives to traditional engagements including platforms that allow asynchronous or “over time” engagement: KOLs interact with platforms and with each other on their own time, receiving information and offering feedback outside the model of a group discussion. This podcast sponsored by Impetus Digital explores the opportunities and benefits of platforms that deliver asynchronous engagement, noting dramatic increases in HCP/KOL participation and cost-per-word.

Objectives: At the end of this series of podcasts, the participant should be able to:Discuss the functions and activities of key external partnersIdentify potential areas for compliant collaboration by MSLs with key external partners